Efficacy of InteguSeal for Surgical Skin Preparation in Patients Undergoing Total Joint Replacement
Single-Center, Randomized Trial to Study the Efficacy of InteguSeal for Surgical Skin Preparation in Patients Undergoing
Sponsor: Kimberly-Clark Corporation
Listed as NCT00829556, this NA trial focuses on Prosthetic Joint Infection and Surgical Skin Infection and remains completed. Sponsored by Kimberly-Clark Corporation, it has been updated 5 times since 2008, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Apr 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kimberly-Clark Corporation
- Rothman Institute Orthopaedics
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Philadelphia, United States